Q1 2025 iRhythm Technologies Inc Earnings Call Transcript

May 1, 2025 / 08:30 PM GMT

Release Date Price: €93.5

Transcript 10-Q

Key Points

Positve

iRhythm Technologies Inc (IRTC) reported a strong start to 2025 with a revenue of $158.7 million, representing over 20% growth compared to the first quarter of 2024.
The company achieved significant market penetration in the US and international markets, with strong demand for its XO monitor and GOAT products.
iRhythm surpassed 10 million cumulative patient reports, highlighting its commitment to superior patient care.
The company is expanding into primary care channels, with nearly one-third of long-term continuous monitoring volumes now originating from primary care physicians.
iRhythm is making progress in international markets, including a commercial launch in Japan, and is working on improving reimbursement rates through clinical evidence.

Negative

The company is facing challenges with reimbursement rates in Japan, which are currently set at the Holter monitoring rate, impacting expected revenue contributions.
iRhythm continues to incur significant legal and consulting fees related to FDA remediation efforts and DOJ subpoena activities.
The company is experiencing pricing headwinds in the US market, which could impact revenue growth.
There are ongoing concerns about tariffs and their potential impact on supply chain and costs.
Despite strong revenue growth, iRhythm reported an adjusted net loss of $30.3 million for the first quarter of 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IRTC.OQ - iRhythm Technologies Inc
Q1 2025 iRhythm Technologies Inc Earnings Call
May 01, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon.

Thank you for attending the iRhythm Technologies Inc. First quarter 2025 earnings conference call. My name is Cameron, and I'll be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press 1 on your telephone keypad.

Due to the interest of time, we ask that you ask one question and to reach you for any follow-up questions. Again, due to the interest of time, we ask that you ask one question and to recu for any follow-up questions. I would now like to pass the conference over to your host Stephanie Zadkovich, director of investor relations. They

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.